Endotoxin elimination in sepsis: physiology and therapeutic application.
about
Balancing Innate Immunity and Inflammatory State via Modulation of Neutrophil Function: A Novel Strategy to Fight SepsisGrowth and Development Symposium: Endotoxin, inflammation, and intestinal function in livestockTowards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnectThe Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged GroupsBinding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2.The lipid-bound apolipoprotein A-I cysteine mutant (N74C) inhibits the activation of NF-κB, JNK and p38 in endotoxemic mice and RAW264.7 cells.Lipopolysaccharide derived from the rumen down-regulates stearoyl-CoA desaturase 1 expression and alters fatty acid composition in the liver of dairy cows fed a high-concentrate diet.Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.Structural Basis for Antibody Recognition of Lipid A: INSIGHTS TO POLYSPECIFICITY TOWARD SINGLE-STRANDED DNA.Impact of polymer-modified gold nanoparticles on brain endothelial cells: exclusion of endoplasmic reticulum stress as a potential risk factor.Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach.LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides.Current trends in endotoxin detection and analysis of endotoxin-protein interactions.Treatment of endotoxaemia and septicaemia in the equine patient.Polyspecificity of Anti-lipid A Antibodies and Its Relevance to the Development of Autoimmunity.Low-dose polymyxin: an option for therapy of Gram-negative sepsis.Effect of simvastatin on mitochondrial enzyme activities, ghrelin, hypoxia-inducible factor 1α in hepatic tissue during early phase of sepsis.Encapsulated Hsp70 decreases endotoxin-induced production of ROS and TNFα in human phagocytes.Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation.Cationic nanoemulsions bearing ciprofloxacin surf-plexes enhances its therapeutic efficacy in conditions of E. coli induced peritonitis and sepsis.Efficacy of specific IgY for treatment of lipopolysaccharide-induced endotoxemia using a mouse model.Antimicrobial Activities and Mechanisms of Magnesium Oxide Nanoparticles (nMgO) against Pathogenic Bacteria, Yeasts, and BiofilmsChromatographic Removal of Endotoxins: A Bioprocess Engineer's Perspective
P2860
Q26769674-902B498A-0364-4225-BD99-2A4D197F286CQ26828771-E5BD7E2A-05E5-4E4E-97E6-0243E14DC8ECQ26996658-4454A8F6-02A4-442D-A472-C2B88DC39BD6Q30385146-CA19B27D-43EC-406D-BEEF-8876419F9FBEQ33959844-8725F8DA-D4FA-4534-9DB8-B5B52445CDD3Q34516452-2F4D9301-9BA3-43B9-9875-1708D8B69432Q35158646-54C348CD-228F-4F42-8F0B-984D7311F04CQ35691139-5FF15D3A-4D9F-4E17-9C45-3F83495F473DQ35925821-0E166769-B4F7-4519-8F1B-B20919250D7EQ36095589-9E82C8A1-5765-4588-986C-D56F996F6726Q37999739-BCB7A055-0FED-464F-B211-2482DA86E7C9Q38177267-CEB3AD9B-6D49-4687-8742-CE0F3E24C328Q38728365-31C18669-E89E-4C6E-910F-3F0182CB3D6BQ38906880-D41524CB-2521-4929-9221-25F9B4DDDCC9Q40059466-7E513898-3D4A-44E0-99E2-B2A25E59B89AQ40272427-62090188-48B7-431B-B421-594B15FCE71CQ41043832-7FE8194F-4491-4C22-9243-8DFECEFAC777Q41176098-722E6C2B-1392-48A7-B158-7AC2795404FAQ50493224-901A3BEE-1B66-4643-936E-D426FD7A91FBQ54290966-0FF12403-5582-4B0A-A258-368FB82AA09EQ54352567-9BD16CF1-3018-484E-AEED-FF64726BF357Q58618201-E97CA472-4FD1-47F3-8021-1FADCA3AF5BFQ58691968-D774912A-A0D4-42F0-A488-9B097FF6CEDF
P2860
Endotoxin elimination in sepsis: physiology and therapeutic application.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endotoxin elimination in sepsis: physiology and therapeutic application.
@en
Endotoxin elimination in sepsis: physiology and therapeutic application.
@nl
type
label
Endotoxin elimination in sepsis: physiology and therapeutic application.
@en
Endotoxin elimination in sepsis: physiology and therapeutic application.
@nl
prefLabel
Endotoxin elimination in sepsis: physiology and therapeutic application.
@en
Endotoxin elimination in sepsis: physiology and therapeutic application.
@nl
P2093
P2860
P1476
Endotoxin elimination in sepsis: physiology and therapeutic application.
@en
P2093
Hendrik Bracht
Klaus Buttenschoen
Peter Radermacher
P2860
P2888
P304
P356
10.1007/S00423-010-0658-6
P407
P577
2010-06-27T00:00:00Z